Leonard Talarico, DPM
Podiatrist · Pooler, GANPI 1831106988
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 56.8% of the total.
Across 63 payments — averaging $129.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$5K
- Arthrex$2K
- Osteomed LLC$1K
- Zimmer Biomet$349
- Melinta Therapeutics, LLC$116
- Stryker$108
- plus $213 from 8 others
What the payments were for
- Travel & lodging$4,44254%
- Food & beverage$2,18027%
- Education$1,54719%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 35 | $4,636 |
| Arthrex | 1 | $1,547 |
| Osteomed LLC | 5 | $1,199 |
| Zimmer Biomet | 2 | $349 |
| Melinta Therapeutics, LLC | 1 | $116 |
| Stryker(2 entities) | 7 | $108 |
| Organogenesis Inc. | 4 | $99 |
| Smith+Nephew | 2 | $32 |
| Kerecis Limited | 1 | $20 |
| Convatec Inc. | 1 | $16 |
| Amgen | 1 | $14 |
| Next Science LLC | 1 | $13 |
| Acera Surgical, Inc. | 1 | $13 |
| GRT US Holding, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$2,195
- EXT-Other$994
- Lapiplasty$680
- LAPIPLASTY SYSTEM 1$663
- CANNULATED SCREWS$349
- Baxdela$116
How this compares
$8,169 in reported general payments places this provider in the 85th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 13 | $277 |
| Celecoxib | 19 | $187 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Pooler
- Allen RaphaelSmyrna$324K
- Ira KrausFort Oglethorpe$223K
- Stephen BarrettMarietta$82K
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Ryan FitzgeraldCanton$43K
- Margo JimenezAtlanta$19K
- Samantha MinerSmyrna$17K
- Robson SpinolaJesup$15K
- Christopher CorwinJohns Creek$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.